TOWA PHARMACEUTICAL CO.,LTD.
4553 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 門真市新橋町２番１１号
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
TOWA PHARMACEUTICAL CO., LTD. is a prominent Japanese pharmaceutical company dedicated to the development, manufacturing, and marketing of innovative medical products. Established with a commitment to improving healthcare, TOWA specializes in a diverse range of therapeutic areas, including generic pharmaceuticals and unique proprietary drugs. With a strong emphasis on research and development, TOWA is focused on delivering high-quality, accessible medications to meet the needs of patients and healthcare providers. The company leverages advanced technology and robust quality control measures to ensure the efficacy and safety of its products. TOWA is positioned as a key player in the pharmaceutical industry, contributing to the advancement of healthcare solutions both in Japan and globally.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-27 08:01 |
Inside Information Statement
臨時報告書
|
Japanese | 24.0 KB | |
| 2025-06-24 05:01 |
Internal Control over Financial Reporting
内部統制報告書－第69期(2024/04/01－2025/03/31)
|
Japanese | 23.6 KB | |
| 2025-06-24 05:00 |
Annual Report
有価証券報告書－第69期(2024/04/01－2025/03/31)
|
Japanese | 1.4 MB | |
| 2025-06-24 05:00 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-11-13 01:01 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB | |
| 2024-11-13 01:00 |
Interim Report
半期報告書－第69期(2024/04/01－2025/03/31)
|
Japanese | 207.6 KB | |
| 2024-07-10 09:04 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-07-10 09:00 |
Regulatory News Service
訂正有価証券報告書－第68期(2023/04/01－2024/03/31)
|
Japanese | 849.4 KB | |
| 2024-06-27 05:54 |
Inside Information Statement
臨時報告書
|
Japanese | 24.9 KB | |
| 2024-06-26 02:02 |
Internal Control over Financial Reporting
内部統制報告書－第68期(2023/04/01－2024/03/31)
|
Japanese | 21.7 KB | |
| 2024-06-26 02:01 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-06-26 02:01 |
Annual Report
有価証券報告書－第68期(2023/04/01－2024/03/31)
|
Japanese | 1.4 MB | |
| 2024-02-14 01:01 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB | |
| 2024-02-14 01:00 |
Quarterly Report
四半期報告書－第68期第3四半期(2023/10/01－2023/12/31)
|
Japanese | 169.1 KB | |
| 2023-11-14 01:00 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Antibiotice S.A. | Romania | ATB | |
|
Aran Research & Development (1982) Ltd. | Israel | ARAN | |
|
Asarina Pharma AB | Sweden | ASAP | |
| ASKA Pharmaceutical Holdings CO., Ltd. | Japan | 4886 | ||
|
Astellas Pharma Inc. | Japan | 4503 | |
|
AstraZeneca PLC | United Kingdom | AZN | |
|
Basilea Pharmaceutica AG | Switzerland | BSLN | |
|
Bayer AG | Germany | BAY | |
|
Biofarm S.A. | Romania | BIO | |
|
Biogened Spolka Akcyjna | Poland | BGD |